Long-acting injectable ART: next revolution in HIV?

Lancet. 2017 Sep 23;390(10101):1468-1470. doi: 10.1016/S0140-6736(17)31962-1. Epub 2017 Jul 24.

Authors

Mark A Boyd¹, David A Cooper²

Affiliations

¹ University of Adelaide, Lyell McEwin Hospital, Elizabeth Vale, SA 5112, Australia; The Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: [email protected].
² The Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.

PMID: 28750936
DOI: 10.1016/S0140-6736(17)31962-1

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents*
Delayed-Action Preparations
HIV Infections / drug therapy*
Humans

Substances

Anti-HIV Agents
Delayed-Action Preparations